|
2025
|
Invention
|
Oncology combination therapy and methods of use. The present disclosure relates to combination th... |
|
2024
|
Invention
|
Use of plinabulin in combination with immune checkpoint inhibitors.
Disclosed herein are composi... |
|
|
Invention
|
Therapeutic compositions and methods for treating checkpoint inhibitor-resistant tumors using pli... |
|
|
Invention
|
Oncology combination therapy and methods of use. Disclosed herein is the treatment of cancer by a... |
|
|
Invention
|
Plinabulin compositions.
Disclosed herein are plinabulin polymorphs, compositions, their use and... |
|
|
Invention
|
Oncology combination therapy and methods of use. Disclosed herein is the treatment of cancer by c... |
|
2023
|
Invention
|
Tubulin binding compounds and therapeutic use thereof. Disclosed herein are compounds that can bi... |
|
|
Invention
|
Stable plinabulin formulations and methods of their preparation and use.
Described herein are pl... |
|
|
Invention
|
Stable plinabulin formulations and methods of their preparation and use. Described herein are pli... |
|
2022
|
Invention
|
Methods for treating cancers and tumors.
Disclosed herein are methods of treating, preventing or... |
|
|
Invention
|
Methods for treating cancers and tumors. Disclosed herein are methods of treating, preventing or ... |
|
|
Invention
|
Method of stimulating neutrophil survival and reducing neutropenia. Disclosed herein are plinabul... |
|
|
Invention
|
Impurity in plinabulin or preparation thereof, and use thereof.
The present invention relates to... |
|
|
Invention
|
Therapeutic compositions and methods for treating tumors.
Disclosed herein are methods of treati... |
|
|
Invention
|
Therapeutic compositions and methods for treating tumors. Disclosed herein are methods of treatin... |
|
|
Invention
|
Plinabulin compositions. Disclosed herein are plinabulin polymorphs, compositions, their use and ... |
|
|
Invention
|
Composition and method for reducing neutropenia. Disclosed herein are methods of reducing neutrop... |
|
2021
|
Invention
|
Compositions and methods for generating anti-tumor immune response. Disclosed herein are composit... |
|
|
Invention
|
Method of treating cancer associated with a ras mutation. Disclosed herein are methods of treatin... |
|
|
Invention
|
Triple combination therapy for enhancing cancer cell killing in cancers with low immunogenicity. ... |
|
|
Invention
|
Compositions containing tucaresol or its analogs. Disclosed herein are compositions including a c... |
|
2020
|
Invention
|
Tucaresol derivatives and uses thereof.
Disclosed herein are tucaresol derivative compound and c... |
|
|
Invention
|
Tucaresol derivatives and uses thereof. Disclosed herein are tucaresol derivative compound and co... |
|
|
Invention
|
Methods and compositions for treating iron disorders.
Disclosed herein are methods of reducing, ... |
|
|
Invention
|
Methods and compositions for treating iron disorders. Disclosed herein are methods of reducing, p... |
|
|
P/S
|
Pharmaceutical products and preparations for the prevention and treatment of cancer and side-effe... |
|
|
P/S
|
Pharmaceutical products and preparations for the prevention
and treatment of cancer and side-eff... |
|
2019
|
Invention
|
Methods of treating cancer using tubulin binding agents.
Described herein includes a method of t... |
|
|
Invention
|
Methods of treating cancer using tubulin binding agents. Described herein includes a method of tr... |
|
|
Invention
|
Method and composition for stimulating immune response.
A composition for administration to a su... |
|
|
Invention
|
Method and composition for stimulating immune response. A composition for administration to a sub... |
|
|
Invention
|
Composition and method of treating cancer associated with egfr mutation.
Disclosed herein are pl... |
|
|
Invention
|
Composition and method of treating cancer associated with egfr mutation. Disclosed herein are pli... |
|
|
Invention
|
Composition and method for reducing chemotherapy-induced neutropenia via the administration of pl... |
|
|
Invention
|
Composition and method for reducing thrombocytopenia. Disclosed herein are methods of reducing or... |
|
|
Invention
|
Composition and method for reducing thrombocytopenia via the administration of plinabulin. Disclo... |
|
2018
|
Invention
|
Method of treating a brain tumor. Disclosed herein are methods of treating a brain tumor by admin... |
|
|
Invention
|
Compositions of plinabulin and use thereof.
Disclosed herein are compositions and methods of pre... |
|
|
Invention
|
Compositions of plinabulin and use thereof. Disclosed herein are compositions and methods of prev... |
|
|
Invention
|
Method of reducing chemotherapy-induced neutropenia. Disclosed herein are plinabulin and the use ... |
|
|
Invention
|
Method of reducing neutropenia. Disclosed herein are plinabulin and the use for reducing neutrope... |
|
2017
|
P/S
|
pharmaceuticals, namely, anti-inflammatories; pharmaceuticals, medications and preparations for t... |
|
|
P/S
|
Pharmaceuticals, namely, anti-inflammatories; pharmaceuticals, medications and preparations for t... |
